<table border="1"><tr><th>Name UICPA</th><td><ul><li>4-({6-amino-5-bromo-2 -[(4-cyanophenyl)amino]pyrimidine-4-yl}oxy) -3,5-dimethylbenzonitrile</li></ul></td></tr><tr><th>N | o | CAS</th><td><ul><li>269055-15-4</li></ul></td></tr><tr><th>N | o | ECHA</th><td><ul><li>100.207.546</li></ul></td></tr><tr><th>ATC Code</th><td><ul><li>J05 | AG04</li></ul></td></tr><tr><th>SMILES</th><td><ul><li>Cc3cc(C#N)cc(C)c3Oc2nc(Nc1ccc(C#N)cc1)nc(N)c2Br | PubChem |, | 3D view</li></ul></td></tr><tr><th>InChI</th><td><ul><li>InChI | 3D view | InChI=1/C20H15BrN6O/c1-11-7-14(10-23)8-12(2)17(11)28-19-16(21)18(24)26-20(27-19)25-15-5-3-13(9-22)4-6-15/h3-8H,1-2H3,(H3,24.25,26,27)</li></ul></td></tr><tr><th>Formula</th><td><ul><li>C | 20 | H | 15 | BrN | 6 | O | [Isomeres]</li></ul></td></tr><tr><th>Molar mass</th><td><ul><li>435,277 Â± 0.02 g/mol | C 55.19%, H 3.47%, Br 18.36%, N 19.31 %, O 3.68%,</li></ul></td></tr><tr><th>Therapeutic class</th><td><ul><li>Antiretroviral: Non-nucleoside reverse transcriptase inhibitor</li></ul></td></tr><tr><th>Route of administration</th><td><ul><li>Oral</li></ul></td></tr></table>